Search | Médecins Sans Frontières Access Campaign

25 results found

Statement |

30 April 2014

MSF responds to US Trade 301 Watch List

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines evergreeningfree trade agreementTrans-Pacific Partnership Agreement (TPP)TRIPS PEPFARPHARMACEUTICAL Companies India

Statement |

02 April 2014

Submission to the US Trade Representative Regarding the 2014 Special 301 Review Process

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines free trade agreementTrans-Pacific Partnership Agreement (TPP)TRIPS PEPFAR India

Speech |

10 February 2012

Submission to the US Trade Representative Regarding the 2012 Special 301 Review Process

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines Anti-Counterfeiting Trade Agreement (ACTA)free trade agreementTrans-Pacific Partnership Agreement (TPP)TRIPS PEPFAR

Interview |

08 August 2011

Caught in the Middle – HIV Medicines Pricing Sky High in ‘Middle-Income’ Countries

Tags HIV/AIDSIntellectual property and trade HIV/AIDS raltegravirantiretroviral medicines compulsory licencepatent poolTRIPS Brazil

Speech |

14 June 2011

MSF Statement at UN High-Level Meeting on HIV/AIDS

Tags HIV/AIDSIntellectual property and trade HIV/AIDStuberculosis antiretroviral medicines TRIPS Thailand

Feature story |

20 September 2010

New Report highlights India's role as "lifeline" for patients in developing countries

Tags HIV/AIDSIntellectual property and trade antiretroviral medicines TRIPS India

Statement |

21 April 2010

MSF Statement on the Pipeline Case in Brazil

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines TRIPS Brazil

Feature story |

03 March 2010

MSF's Statement regarding the 2010 Special 301 Review

Tags Intellectual property and trade antiretroviral medicines compulsory licenceDoha DeclarationTRIPS PEPFAR

Feature story |

12 January 2010

Provisions in U.S. Domestic Health Care Legislation Could Limit Access to Vaccines and New Class of Drugs

Tags HIV/AIDSIntellectual property and trade antiretroviral medicinesvaccines data exclusivityfree trade agreementTRIPS

Press release |

15 March 2007

MSF denounces Abbott’s move to withhold medicines from people in Thailand

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines compulsory licenceTRIPS Abbott Thailand

Press release |

14 November 2006

Five years after Doha, drug prices are on the rise

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines TRIPS

Press release |

11 January 2006

US-Thailand Free Trade Agreement: MSF Calls on Thailand to Protect Access to Medicines in the Face of US Pressure

Tags Intellectual property and trade HIV/AIDS antiretroviral medicines free trade agreementTRIPS Thailand

Press release |

06 July 2005

MSF talking points for the Group of Eight (G8) meeting in Scotland, July 2005

Tags HIV/AIDSIntellectual property and tradeResearch and developmentTropical & neglected diseasesTuberculosis HIV/AIDSsleeping sicknesstuberculosis antiretroviral medicines diagnostic testsTRIPS

Issue brief |

21 April 2005

Prognosis: short-term relief, long-term pain

Tags Intellectual property and trade antiretroviral medicines TRIPS India

Press release |

11 March 2005

New Guatemalan law and intellectual property provisions in DR-CAFTA threaten access to affordable medicines

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines free trade agreementTRIPS UNAIDSWorld Health Organization Guatemala

Press release |

13 December 2003

US Pressure Threatening Access to Medicines in Central America

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines free trade agreementTRIPS GuatemalaHonduras

Press release |

19 November 2003

Regional and Bilateral Trade Agreements Must Not Erode Patient Rights

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines free trade agreementTRIPS

Press release |

16 October 2003

MSF Welcomes Decision of South African Competition Commission to Promote Access to Medicines

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines compulsory licenceTRIPS Boehringer IngelheimGlaxoSmithKline South Africa

Press release |

28 August 2003

Access to affordable medicines under attack in the Americas

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines free trade agreementTRIPS

Press release |

27 November 2002

Scaling up HIV/AIDS treatment jeopardized by WTO negotiations

Tags HIV/AIDSIntellectual property and trade HIV/AIDS antiretroviral medicines TRIPS

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

MSF responds to US Trade 301 Watch List

Submission to the US Trade Representative Regarding the 2014 Special 301 Review Process

Submission to the US Trade Representative Regarding the 2012 Special 301 Review Process

Caught in the Middle – HIV Medicines Pricing Sky High in ‘Middle-Income’ Countries

MSF Statement at UN High-Level Meeting on HIV/AIDS

New Report highlights India's role as "lifeline" for patients in developing countries

MSF Statement on the Pipeline Case in Brazil

MSF's Statement regarding the 2010 Special 301 Review

Provisions in U.S. Domestic Health Care Legislation Could Limit Access to Vaccines and New Class of Drugs

MSF denounces Abbott’s move to withhold medicines from people in Thailand

Five years after Doha, drug prices are on the rise

US-Thailand Free Trade Agreement: MSF Calls on Thailand to Protect Access to Medicines in the Face of US Pressure

MSF talking points for the Group of Eight (G8) meeting in Scotland, July 2005

Prognosis: short-term relief, long-term pain

New Guatemalan law and intellectual property provisions in DR-CAFTA threaten access to affordable medicines

US Pressure Threatening Access to Medicines in Central America

Regional and Bilateral Trade Agreements Must Not Erode Patient Rights

MSF Welcomes Decision of South African Competition Commission to Promote Access to Medicines

Access to affordable medicines under attack in the Americas

Scaling up HIV/AIDS treatment jeopardized by WTO negotiations